Broadcom's Post-Earnings Dip Is a Compelling Buying Opportunity

Broadcom reported 48% year-over-year revenue growth in fiscal Q2 and AI chip revenue surged 143% to $10.8 billion, nearly half of total quarterly revenue. Management guided fiscal Q3 revenue to $29.4 billion, implying 32.5% sequential growth, reinforcing the view that AI infrastructure demand remains strong. The article frames the post-earnings selloff as an opportunity, citing continued market-share gains and rising AI capital spending by major tech customers.

Analysis

AVGO’s setup is less about one quarter and more about the capex regime shift behind it. When hyperscalers move from experimentation to deployment, the mix of spend rotates from general-purpose compute toward custom silicon, networking, and power-efficient rack design — areas where AVGO is structurally levered and where margins should remain unusually resilient. The market is still treating AI infrastructure as a cyclical enthusiasm trade, but the business mix suggests a longer-duration annuity: once a custom program is embedded, switching costs rise sharply and reuse across next-gen training clusters becomes a multi-year tailwind.

The second-order winner is likely not just AVGO but the entire AI infrastructure stack that sits one layer below model builders. If custom ASIC adoption keeps rising, it pressures GPU attach rates at the margin in workloads where latency, efficiency, and cost per token matter more than flexibility; that is a subtle headwind for NVDA/AMD share at the edges, not a thesis breaker. It also reinforces demand for optical interconnect, advanced packaging, and power management suppliers, because each incremental AI dollar increasingly migrates into rack-level complexity rather than standalone chips.

The main risk is not demand slowing, but expectations compounding faster than execution. AVGO can beat on revenue and still disappoint if investors want an even steeper guide; that makes the stock vulnerable to short-term de-rating despite healthy fundamentals. Over the next 1-3 months, the key check is whether hyperscaler commentary confirms continued AI capex acceleration into 2027; over 6-12 months, the danger is that custom silicon gains more share but on lower incremental economics than the market is capitalizing today.

The contrarian view is that the post-earnings pullback may be only partially washed out because the market is still underestimating the quality of AVGO’s growth, but overestimating its near-term speed. This is a classic setup where the underlying business is better than the stock price, yet upside likely comes from time and compounding rather than an immediate rerate. In that context, the best risk/reward is to buy weakness and avoid chasing strength, especially if broader AI multiples remain fragile.

Key Decisions for Investors

• Buy AVGO on further pullbacks over the next 1-3 weeks; risk/reward favors adding when sentiment cools rather than on up days. Base case is a 12-month compounder with multiple expansion optionality if AI capex guidance keeps firming.
• Pair trade: long AVGO / short a basket of higher-beta AI hardware names such as AMD or a smaller NVDA hedge for 1-3 months. The trade expresses preference for custom-silicon economics and customer lock-in over more crowded GPU exposure.
• Use AVGO Jan-2027 calls or call spreads to capture the 6-12 month capex cycle without paying full spot volatility; this fits a thesis that the real monetization is a multi-quarter ramp, not a one-print trade.
• If you are already long NVDA, trim marginal exposure into AVGO strength and rotate some capital toward infrastructure adjacencies. The risk is not outright GPU collapse, but relative underperformance if ASIC adoption continues to take share at the workload level.
• Watch hyperscaler earnings and capex comments as the next catalyst window; if commentary softens, reduce AVGO exposure quickly because the stock can de-rate faster than fundamentals roll over.